Castleview Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
MSV
AP
CA
SC
FFBTD
FFA
GI
VWM
SCA
Castleview Partners's GILD Position: Q3 2026 in Review
Castleview Partners increased its Gilead Sciences (GILD) stake by 14% in Q3 2026, buying an estimated $122K and bringing the position to 7,155 shares worth $1.07M. The position accounts for 0.47% of the portfolio, ranked #49.
Castleview Partners first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Castleview Partners held 7,155 shares of Gilead Sciences worth $1.07M as of Q3 2026.
- Castleview Partners bought 869 Gilead Sciences shares in Q3 2026, an estimated $122K.
- Gilead Sciences made up 0.47% of Castleview Partners's portfolio in Q3 2026, its #49 holding.
- Castleview Partners first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
- 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Castleview Partners's 13F filing for Q3 2026, filed 9 Oct 2026.